The antidiabetic drug rosiglitazone blocks Kv1.5 potassium channels in an open state

Lee, HM; Hahn, SJ; Choi, BH

Choi, BH (通讯作者),Jeonbuk Natl Univ, Inst Med Sci, Dept Pharmacol, Med Sch, Jeonju 54097, South Korea.

KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2022; 26 (2): 135

Abstract

An antidiabetic drug, rosiglitazone is a member of the drug class of thiazolidinedione. Although restrictions on use due to the possibility of heart t......

Full Text Link